000 | 02350nam a22003617a 4500 | ||
---|---|---|---|
008 | 210217s20202020 xxu||||| |||| 00| 0 eng d | ||
022 | _a2008-9783 | ||
024 | _a10.34172/jlms.2020.63 [doi] | ||
024 | _aPMC7736946 [pmc] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a33425289 | ||
245 | _aLaser Treatment of Darier Disease: Report of Two Cases and Systematic Review of the Literature. [Review] | ||
251 | _aJournal of Lasers in Medical Sciences. 11(4):395-404, 2020 Fall. | ||
252 | _aJ. lasers med. sci.. 11(4):395-404, 2020. | ||
253 | _aJournal of lasers in medical sciences | ||
260 | _c2020 | ||
260 | _fFY2021 | ||
265 | _sppublish | ||
266 | _d2021-02-17 | ||
520 | _aIntroduction: Darier disease (DD) is a chronic disease with high morbidity and limited treatment options. Laser efficacy in the treatment of DD remains understudied. Methods: A literature search conducted between 07/21/2017 and 05/05/2018 identified all original cases of DD treated with laser therapy. Results: Outcomes from 24 patients were reviewed, 22 patients were identified in the literature and 2 cases are included from our institution. Five types of lasers were identified [CO2 laser, Er:YAG laser, pulse dye laser [PDL], diode laser, erbium-doped fiber laser], with CO2 (46%) and PDL (42%) being the most common. Seventy-nine percent of patients were treated with more than one procedure (average, 3 procedures). The estimated body surface treated with each session ranged from 5%-50%. The most common adverse events came from CO2 and Er:YAG lasers and included dyspigmentation, pain, and post-laser erythema and edema. The time to response (mode, 1 month) was only reported in half of the studies. Conclusion: Laser treatments appear to be a promising alternative to standardized therapies in DD. Copyright (c) 2020 J Lasers Med Sci. | ||
546 | _aEnglish | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aDermatology | ||
656 | _aMedicine/Dermatology | ||
657 | _aJournal Article | ||
657 | _aReview | ||
700 | _aDeKlotz, Cynthia Marie Carver | ||
700 | _aFricke, Michelle A | ||
790 | _aDeKlotz CMC, Fricke MA, Kent RA, O'Brien KF | ||
856 |
_uhttps://dx.doi.org/10.34172/jlms.2020.63 _zhttps://dx.doi.org/10.34172/jlms.2020.63 |
||
942 |
_cART _dArticle |
||
999 |
_c6116 _d6116 |